Bronwyn MacInnis, Ph.D.
Director of Pathogen Genomic Surveillance; Institute Scientist
Bronwyn MacInnis is director of pathogen genomic surveillance in the Infectious Disease and Microbiome Program at the Broad Institute of MIT and Harvard, where she is also an institute scientist. She also co-leads the Broad’s multidisciplinary Global Health Initiative and is a visiting scientist at the Harvard T.H. Chan School of Public Health.
Her work focuses on understanding how pathogens of global importance evolve as they spread in time and space, and how this information can be translated into practical applications for public health. Her primary focus is on leveraging advances in genomics and data science to improve our ability to detect, track, and limit the spread of malaria parasites and viral threats including Ebola, Zika, and SARS-CoV-2. MacInnis also focuses on building local capacity to integrate these into public health practice, both domestically and in lower resource settings around the world. She co-led the Broad Institute’s large scale COVID genomic surveillance program and now co-leads the CDC’s Pathogen Genomics Center of Excellence for the Northeast, working closely with the Massachusetts Department of Public Health and the US Centers for Disease Control and Prevention. She also served as a technical advisor to the World Health Organization to develop use cases for genomic data in malaria surveillance and control, and data sharing guidelines for global pandemic preparedness strategy.
Prior to joining the Broad Institute, MacInnis was a senior scientific program manager at the Wellcome Sanger Institute in the UK, where she co-led the Malaria Genomic Epidemiology Network (MalariaGEN), a global data sharing community aimed at translating genome science into tools for malaria control and elimination. She completed her Ph.D. at the University of Alberta in Canada, and was a Human Frontiers in Science Program Postdoctoral Fellow at Stanford University.
Contact Bronwyn MacInnis via email at email@example.com.